{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:45:57Z","timestamp":1760298357123},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T00:00:00Z","timestamp":1299628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s11010-011-0774-9","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T15:34:38Z","timestamp":1299598478000},"page":"59-63","source":"Crossref","is-referenced-by-count":12,"title":["Lipid profiles and oxidative stress parameters in male and female hemodialysis patients"],"prefix":"10.1007","volume":"353","author":[{"given":"A.","family":"Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"de Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ruiz-Requena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"774_CR1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1523-1755.2001.59780128.x","volume":"78S","author":"JM Roob","year":"2001","unstructured":"Roob JM, Rabold T, Hayn T, Khoschsorur G, Resch U, Holzer H, Winklhofer-Roob BM (2001) Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD. Kidney Int 78S:128\u2013136 Suppl","journal-title":"Kidney Int"},{"key":"774_CR2","first-page":"238","volume":"16","author":"JM Akker Van den","year":"2003","unstructured":"Van den Akker JM, Bredie SJ, Diepenveen SH, van Tits LJ, Stalenhoef AF, Van Leusen R (2003) Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C reactive protein and in vivo oxidized LDL. J Nephrol 16:238\u2013244","journal-title":"J Nephrol"},{"key":"774_CR3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000045210","volume":"80","author":"F Locatelli","year":"1998","unstructured":"Locatelli F, Del Vecchio L, Manzoni C (1998) Morbidity and mortality on maintenance haemodialysis. Nephron 80:380\u2013400","journal-title":"Nephron"},{"key":"774_CR4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/ndt\/gfp756","volume":"25","author":"JP Kuijk Van","year":"2010","unstructured":"Van Kuijk JP, Flu WJ, Chonchol M, Welten GMJM, Verhagen HJM, Bax JJ, Poldermans D (2010) The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant 25:1882\u20131888","journal-title":"Nephrol Dial Transplant"},{"key":"774_CR5","first-page":"119","volume":"30","author":"M Junyent","year":"2010","unstructured":"Junyent M, Martinez M, Borras M, Bertriu A, Coll B, Craver L, Marco MP, Sarr\u00f3 F, Valdivieso JM, Fernanadez E (2010) Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project. Nefrologia 30:119\u2013126","journal-title":"Nefrologia"},{"key":"774_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) CAD in chronic renal disease: clinical epidemiology of CAD in chronic renal disease. Am J Kidney Dis 32:112\u2013119","journal-title":"Am J Kidney Dis"},{"key":"774_CR7","first-page":"53","volume":"62","author":"C Wanner","year":"1997","unstructured":"Wanner C, Zimmerman J, Quaschning T, Galle J (1997) Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int 62:53\u201355 Suppl","journal-title":"Kidney Int"},{"key":"774_CR8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198208053070601","volume":"307","author":"PJ Nestel","year":"1982","unstructured":"Nestel PJ, Fidge NH, Tan MH (1982) Increased lipoprotein-remnant formation in chronic renal failure. New Eng J Med 307:329\u2013333","journal-title":"New Eng J Med"},{"key":"774_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/ajkd.1998.v32.pm9820472","volume":"32","author":"BL Kasiske","year":"1998","unstructured":"Kasiske BL (1998) Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32:142\u2013156","journal-title":"Am J Kidney Dis"},{"key":"774_CR10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0026-0495(77)90009-9","volume":"26","author":"JD Brunzell","year":"1997","unstructured":"Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadaa L, Sherrard DJ (1997) Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26:903\u2013907","journal-title":"Metabolism"},{"key":"774_CR11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.1992.204","volume":"41","author":"M Senti","year":"1992","unstructured":"Senti M, Romero R, Pedro-Botert J, Pelegri A, Nogues X, Rubies-Part J (1992) Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394\u20131399","journal-title":"Kidney Int"},{"key":"774_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000077381","volume":"96","author":"K Pawlak","year":"2004","unstructured":"Pawlak K, Pawlak D, Mysliwiec M (2004) Oxidative stress influences CC-Chemokine levels in hemodialyzed patients. Nephron Physiol 96:105\u2013112","journal-title":"Nephron Physiol"},{"key":"774_CR13","first-page":"336","volume":"15","author":"ZA Massy","year":"2002","unstructured":"Massy ZA, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: Markers and management. J Nephrol 15:336\u2013341","journal-title":"J Nephrol"},{"key":"774_CR14","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1681\/ASN.V12122747","volume":"12","author":"M Annuk","year":"2001","unstructured":"Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B (2001) Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12:2747\u20132752","journal-title":"J Am Soc Nephrol"},{"key":"774_CR15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","volume":"55","author":"P Stenvinkel","year":"1999","unstructured":"Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T (1999) Strong association between malnutrition, inflammation, and atherosclerosis in renal failure. Kidney Int 55:1899\u20131911","journal-title":"Kidney Int"},{"key":"774_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0272-6386(12)70171-3","volume":"22","author":"D Schlondorff","year":"1993","unstructured":"Schlondorff D (1993) Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22:72\u201382","journal-title":"Am J Kidney Dis"},{"key":"774_CR17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00041433-199706000-00008","volume":"8","author":"TJ Lyons","year":"1997","unstructured":"Lyons TJ, Jenkins AJ (1997) Lipoprotein glycation and its metabolic consequences. Curr Opin Lipidol 8:174\u2013180","journal-title":"Curr Opin Lipidol"},{"key":"774_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0021-9150(98)00192-0","volume":"142","author":"N Sakata","year":"1999","unstructured":"Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S (1999) Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis 142:67\u201377","journal-title":"Atherosclerosis"},{"key":"774_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/meta.2001.19486","volume":"50","author":"D O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne D, Devaraj S, Islam KN, Collazo R, McDonald L, Grundy S (2001) Low-density (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. Metabolism 50:207\u2013215","journal-title":"Metabolism"},{"key":"774_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000045900","volume":"87","author":"F Bergesio","year":"2001","unstructured":"Bergesio F, Monzani G, Cinti R, Cirami C, Martinelli F, Salvadori M, Tosi PL (2001) Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids. Nephron 87:127\u2013133","journal-title":"Nephron"},{"key":"774_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2007.05.014","volume":"41","author":"A Osorio","year":"2008","unstructured":"Osorio A, Ortega E, Ruiz-Requena E (2008) Two models of homocysteine behaviour in acute myocardial infarction. Clin Biochem 41:277\u2013281","journal-title":"Clin Biochem"},{"key":"774_CR22","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1681\/ASN.V12102181","volume":"12","author":"AN Friedman","year":"2001","unstructured":"Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH (2001) The kidney and homocysteine metabolism. J Am Soc Nephrol 12:2181\u20132189","journal-title":"J Am Soc Nephrol"},{"key":"774_CR23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0735-1097(95)00508-0","volume":"27","author":"EL Mayer","year":"1996","unstructured":"Mayer EL, Jacobsen DW, Robinson K (1996) Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27:517\u2013527","journal-title":"J Am Coll Cardiol"},{"key":"774_CR24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1194\/jlr.M400290-JLR200","volume":"46","author":"FJ Tinahones","year":"2005","unstructured":"Tinahones FJ, G\u00f3mez-Zumaquero FM, Garrido-Sanchez L, Garcia-Fuentes E, Rojo-Martinez G, Esteva I, Ruiz de Adana MS, Cardona F, Soriguer F (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46:452\u2013457","journal-title":"J Lipid Res"},{"key":"774_CR25","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","volume":"108","author":"J Karvonen","year":"2003","unstructured":"Karvonen J, Paivansalo M, Kesaniemi YA, Horkko S (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108:2107\u20132112","journal-title":"Circulation"},{"key":"774_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11010-005-9047-9","volume":"284","author":"A Kamijo","year":"2006","unstructured":"Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, Numabe A, Takagi M, Hayakawa H, Tabei F, Sugimoto T, Mise N, Omata M, Kimura K (2006) Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Moll Cell Biochem 284:175\u2013182","journal-title":"Moll Cell Biochem"},{"key":"774_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000103910","volume":"106","author":"H Tokuyama","year":"2007","unstructured":"Tokuyama H, Kelly DJ, Zhang Y, Gow RM, Gilbert RE (2007) Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia. Nephron Physiol 106:54\u201362","journal-title":"Nephron Physiol"},{"key":"774_CR28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/107602960300900304","volume":"9","author":"F Kushiya","year":"2003","unstructured":"Kushiya F, Wada H, Sakakura M, Mori Y, Gabazza EC, Nishikawa M, Nobori T, Noguchi M, Izumi K, Nakasaki T, Takagi M, Shiku H (2003) Effects of lipid abnormalities on arteriosclerosis and hemostatic markers in patients under hemodialysis. Clin Appl Thromb Hemost 9:203\u2013210","journal-title":"Clin Appl Thromb Hemost"},{"key":"774_CR29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9150(99)00410-4","volume":"150","author":"KN Islam","year":"2000","unstructured":"Islam KN, O\u2032Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I (2000) \u03b1-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 150:217\u2013224","journal-title":"Atherosclerosis"},{"key":"774_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2008.05.018","volume":"395","author":"A Valli","year":"2008","unstructured":"Valli A, Carrero JJ, Qureshi AR, Gariboto G, Bar\u00e1ny P, Axelsson J, Lindholm B, Stenvinkel P, Anderstam B, Suliman ME (2008) Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta 395:106\u2013110","journal-title":"Clin Chim Acta"},{"key":"774_CR31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)05271-5","volume":"358","author":"S Westphal","year":"2001","unstructured":"Westphal S, Dierkes J, Luley C (2001) Effects of fenofibrate and gemfibrozil on plasma homocysteine. Lancet 358:39\u201340","journal-title":"Lancet"},{"key":"774_CR32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1373\/clinchem.2004.043943","volume":"51","author":"A Zinellu","year":"2005","unstructured":"Zinellu A, Sotgia S, Deiana L, Carru C (2005) Quantification of thiol-containing amino acids linked by disulfides to LDL. Clin Chem 51:658\u2013660","journal-title":"Clin Chem"},{"key":"774_CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/PL00014293","volume":"157","author":"C Stehouwer","year":"1998","unstructured":"Stehouwer C, Jacobs C (1998) Abnormalities of vascular function in hyperhomocysteinemia: Relationship to atherothrombotic disease. Eur J Pediatr 157:107\u2013111","journal-title":"Eur J Pediatr"},{"key":"774_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-007-9441-6","volume":"302","author":"AM Abdulle","year":"2007","unstructured":"Abdulle AM, Gillett MP, Abouchacra S, Sabri SM, Rukhaimi MA, Obineche EN, Singh J (2007) Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients. Mol Cell Biochem 302:195\u2013201","journal-title":"Mol Cell Biochem"},{"key":"774_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tem.2009.12.005","volume":"21","author":"Y Higashi","year":"2010","unstructured":"Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P (2010) IGF-1, oxidative stress and atheroprotection. Trends Endocrinol Metab 21:245\u2013254","journal-title":"Trends Endocrinol Metab"},{"key":"774_CR36","first-page":"1607","volume":"56","author":"PC Fallest-Strobl","year":"1997","unstructured":"Fallest-Strobl PC, Koch DD, Stein JH, McBride PE (1997) Homocysteine: a new risk factor for atherosclerosis. Am Fam Physician 56:1607\u20131612","journal-title":"Am Fam Physician"},{"key":"774_CR37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(99)02153-4","volume":"354","author":"J Dierkes","year":"1999","unstructured":"Dierkes J, Westphal S, Luley C (1999) Serum homocysteine increase after therapy with fenofibrate or bezafibrate. Lancet 354:219\u2013220","journal-title":"Lancet"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-0774-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0774-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T03:53:38Z","timestamp":1637380418000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-0774-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-0774-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}